Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:9766503rdf:typepubmed:Citationlld:pubmed
pubmed-article:9766503lifeskim:mentionsumls-concept:C0023418lld:lifeskim
pubmed-article:9766503lifeskim:mentionsumls-concept:C0087111lld:lifeskim
pubmed-article:9766503lifeskim:mentionsumls-concept:C0567416lld:lifeskim
pubmed-article:9766503lifeskim:mentionsumls-concept:C0699040lld:lifeskim
pubmed-article:9766503lifeskim:mentionsumls-concept:C0011900lld:lifeskim
pubmed-article:9766503lifeskim:mentionsumls-concept:C0205369lld:lifeskim
pubmed-article:9766503lifeskim:mentionsumls-concept:C1521840lld:lifeskim
pubmed-article:9766503pubmed:issue10lld:pubmed
pubmed-article:9766503pubmed:dateCreated1998-10-28lld:pubmed
pubmed-article:9766503pubmed:abstractTextWe previously reported a novel differentiation antigen, which is specifically expressed in stage II double positive (CD4+CD8+) human cortical thymocytes (Park et al, J Exp Med 1993; 178: 1447-1451). This study was designed to investigate the expression pattern of JL1 in various types of leukemic cells from patients and normal hematopoietic cells to evaluate the possibility as a tool for diagnosis and treatment of leukemia. The expression of JL1 antigen was observed in 75.6% of leukemic cases (117 out of 154 leukemic patients tested) on flow cytometric analysis. The percentage of JL1-positive cases of T lineage acute lymphoblastic leukemia (T-ALL) (92.6%) was higher than that of other types of leukemias (75%). The presence of JL1 antigen was also confirmed by immunoblotting and immunoprecipitation. Since the JL1 antigen is selectively expressed on the surface of human leukemic cells but not on the mature human peripheral blood cells, normal bone marrow cells and various types of normal tissues, JL1 could be an excellent candidate for an immunodiagnostic and immunotherapeutic tool for hematopoietic malignancies such as leukemia.lld:pubmed
pubmed-article:9766503pubmed:languageenglld:pubmed
pubmed-article:9766503pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9766503pubmed:citationSubsetIMlld:pubmed
pubmed-article:9766503pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9766503pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9766503pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9766503pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9766503pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9766503pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9766503pubmed:statusMEDLINElld:pubmed
pubmed-article:9766503pubmed:monthOctlld:pubmed
pubmed-article:9766503pubmed:issn0887-6924lld:pubmed
pubmed-article:9766503pubmed:authorpubmed-author:ParkM HMHlld:pubmed
pubmed-article:9766503pubmed:authorpubmed-author:ChungJ KJKlld:pubmed
pubmed-article:9766503pubmed:authorpubmed-author:ParkS HSHlld:pubmed
pubmed-article:9766503pubmed:authorpubmed-author:KUON KNKlld:pubmed
pubmed-article:9766503pubmed:authorpubmed-author:ChungD HDHlld:pubmed
pubmed-article:9766503pubmed:authorpubmed-author:JeeS HSHlld:pubmed
pubmed-article:9766503pubmed:authorpubmed-author:ChoiE YEYlld:pubmed
pubmed-article:9766503pubmed:authorpubmed-author:BaiY QYQlld:pubmed
pubmed-article:9766503pubmed:authorpubmed-author:ParkW SWSlld:pubmed
pubmed-article:9766503pubmed:authorpubmed-author:ParkS YSYlld:pubmed
pubmed-article:9766503pubmed:issnTypePrintlld:pubmed
pubmed-article:9766503pubmed:volume12lld:pubmed
pubmed-article:9766503pubmed:ownerNLMlld:pubmed
pubmed-article:9766503pubmed:authorsCompleteYlld:pubmed
pubmed-article:9766503pubmed:pagination1583-90lld:pubmed
pubmed-article:9766503pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:9766503pubmed:meshHeadingpubmed-meshheading:9766503-...lld:pubmed
pubmed-article:9766503pubmed:meshHeadingpubmed-meshheading:9766503-...lld:pubmed
pubmed-article:9766503pubmed:meshHeadingpubmed-meshheading:9766503-...lld:pubmed
pubmed-article:9766503pubmed:meshHeadingpubmed-meshheading:9766503-...lld:pubmed
pubmed-article:9766503pubmed:meshHeadingpubmed-meshheading:9766503-...lld:pubmed
pubmed-article:9766503pubmed:meshHeadingpubmed-meshheading:9766503-...lld:pubmed
pubmed-article:9766503pubmed:meshHeadingpubmed-meshheading:9766503-...lld:pubmed
pubmed-article:9766503pubmed:meshHeadingpubmed-meshheading:9766503-...lld:pubmed
pubmed-article:9766503pubmed:meshHeadingpubmed-meshheading:9766503-...lld:pubmed
pubmed-article:9766503pubmed:meshHeadingpubmed-meshheading:9766503-...lld:pubmed
pubmed-article:9766503pubmed:meshHeadingpubmed-meshheading:9766503-...lld:pubmed
pubmed-article:9766503pubmed:meshHeadingpubmed-meshheading:9766503-...lld:pubmed
pubmed-article:9766503pubmed:meshHeadingpubmed-meshheading:9766503-...lld:pubmed
pubmed-article:9766503pubmed:meshHeadingpubmed-meshheading:9766503-...lld:pubmed
pubmed-article:9766503pubmed:meshHeadingpubmed-meshheading:9766503-...lld:pubmed
pubmed-article:9766503pubmed:year1998lld:pubmed
pubmed-article:9766503pubmed:articleTitleA cell surface molecule, JL1; a specific target for diagnosis and treatment of leukemias.lld:pubmed
pubmed-article:9766503pubmed:affiliationDepartment of Pathology, Seoul National University College of Medicine, Korea.lld:pubmed
pubmed-article:9766503pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:9766503pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9766503lld:pubmed